Skip to main content
Log in

Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations

  • Original Investigations
  • Published:
Human Genetics Aims and scope Submit manuscript

Summary

We have examined the associations between levels of plasma apolipoprotein (apo) AI, apo CIII and apo AIV and genetic variation in the apo AI-CIII-AIV gene cluster in 162 boys and young men from Belgium aged from 7 to 23 years. Genotypes were determined for six restriction enzymes XmnI, PstI, SstI, PvwIIA-CIII, PvuIIB-AIV and XbaI, and for the G to A substitution at -75 bp in the 5′ region of the apo AI gene. The polymorphism most strongly associated with apo AI levels was the G to A substitution (P=0.025, R 2×100=3.6%) confirming previous observations. The polymorphism most strongly associated with apo CIII levels was that of PvwIIA-CIII (P=0.023, R 2×100=2.9%) in the apo CIII gene. This novel association must be interpreted with caution until it has been confirmed in an independent sample. The polymorphism associated with the largest effect on apo AIV levels was that detected with XbaI in the apo AIV gene, but this association was not statistically significant. Previously reported associations between the SstI polymorphism and triglyceride levels, and between the PstI polymorphism and apo AI levels, were weakly detected in the present sample. Our results show that variation associated with some of the polymorphisms in the apo AI-CIII-AIV cluster makes a small, but statistically significant, contribution to the determination of apo AI and apo CIII levels in this sample of young men and boys. These observations may, in part, explain reported associations between polymorphisms in this gene cluster, differences in plasma lipid and lipoprotein levels, and prevalence of coronary artery disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allain CC, Poon LS, Chan CS (1974) Enzymatic determination of total cholesterol. Clin Chem 20:470–475

    CAS  PubMed  Google Scholar 

  • Anderson RA, Burns TL, Lee J, Swenson D, Bristow JL (1989) Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population. Atherosclerosis 77:227–237

    Article  CAS  PubMed  Google Scholar 

  • Antonarakis SE, Oettgen P, Chakravarti A, Halloran SL, Hudson RR, Feisee L, Karathanasis SK (1988) DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum Genet 80:265–273

    Article  CAS  PubMed  Google Scholar 

  • Berenson GS, Srinivasan SR, Cresanta JL, Foster TA, Webber LS (1981) Dynamic changes in serum lipoproteins in children during adolescence and sexual maturation. Am J Epidemiol 113:157–170

    CAS  PubMed  Google Scholar 

  • Benlian C, Boileau C, Loux N, Pastier D, Masliah J, Coulon M, Nigou M, Ragab A, Guimard J, Ruidavets JB, Bonalti-Pellie C, Fruchart JC, Douste-Blazy P, Bereziat G, Junien C (1991) Extended haplotypes and linkage disequilibrium between 11 markers at the Apo AI-C3-A4 gene cluster on chromosome 11. Am J Hum Genet 48:903–910

    CAS  PubMed  Google Scholar 

  • Berg A, Frey I, Keul J (1986) Apolipoprotein profile in healthy males and its relation to maximum aerobic capacity (MAC). Clin Chim Acta 161:165–171

    Article  CAS  PubMed  Google Scholar 

  • Brown WV, Baginsky ML (1972) Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun 46:375–381

    Article  CAS  PubMed  Google Scholar 

  • Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock MF, Marcel YL, Milne RW, Koizumi J, Mabachi H, Takeda R, Tall AR (1989) Molecular basis of lipid transfer protein deficiency in a family with increased high density lipoproteins. Nature 342:448–451

    CAS  PubMed  Google Scholar 

  • Bucolo GH, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476–482

    CAS  PubMed  Google Scholar 

  • Bury J, Rosseneu M (1988) Apolipoprotein quantitation by ELISA: technical aspects and clinical applications. Rev Immunoassay Techn 1:1–25

    CAS  Google Scholar 

  • Chakravarti A, Phillips JA, Mellits KH, Buetow KH, Seeburg PH (1984) Patterns of polymorphism and linkage disequilibrium suggest independent origins of the human growth hormone gene cluster. Proc Natl Acad Sci USA 81:6085–6089

    CAS  PubMed  Google Scholar 

  • Coleman RT, Gonzales PA, Funke H, Assman G, Levy-Wilson B, Frossard PM (1986) Polymorphisms in the apolipoprotein AI-CIII complex. Mol Biol Med 3:213–228

    CAS  PubMed  Google Scholar 

  • Delmatre JG, Hoffmeier CA, Lacko AG, Roheim PS (1983) Distribution of apolipoprotein AIV between the lipoprotein and the lipoprotein-free fractions of rat plasma: possible role of lecithin cholesterol acyltransferase. J Lipid Res 24:1578–1585

    Google Scholar 

  • Eckardstein A, Funke H, Henke A, Altland K, Benninghoven A, Assman G (1989) Apolipoprotein AI variants, naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. J Clin Invest 84:1722–1730

    Google Scholar 

  • Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13

    Article  CAS  PubMed  Google Scholar 

  • Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

    CAS  PubMed  Google Scholar 

  • Green PHR, Glickman RM, Sandek CD, Blum CB, Tall AR (1979) Human intestinal lipoprotein: studies in chyluric subjects. J Clin Invest 64:233–242

    CAS  PubMed  Google Scholar 

  • Green PHR, Glickman RM, Riley JW, Quinet E (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 65:911–919

    CAS  PubMed  Google Scholar 

  • Haffner SM, Applebaum-Bowden D, Wahl PW, Hoover JJH, Warnick GR, Albers JJ, Hazzard WR (1985) Epidemiological correlates of high density lipoprotein subfractions, apolipoprotein AI, AII and D and lecithin cholesterol acyltransferase: effects of smoking, alcohol and adiposity. Arteriosclerosis 5:169–177

    CAS  PubMed  Google Scholar 

  • Hamsten A, Iselius L, Dahlen G, Fraire U (1986) Genetic and cultural inheritance of serum lipids low and high density lipoprotein cholesterol and serum apolipoproteins AI, AII and B. Atherosclerosis 60:199–208

    Article  CAS  PubMed  Google Scholar 

  • Hartung GH, Reeves RS, Foreyt JP, Patsch W, Gotto AM (1986) Effect of alcohol intake and exercise on plasma high density lipoprotein cholesterol subfractions and apolipoprotein AI in women. Am J Cardiol 58:148–151

    Article  CAS  PubMed  Google Scholar 

  • Herbert PN, Assman G, Gotto AM Jr, Fredrickson DS (1983) Familial lipoprotein deficiency: abetalipoproteinemia, hypobetalipoproteinemia and Tangier disease. In: Stanbury JB, Wyngaarten JB, Fredrickson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 589–621

    Google Scholar 

  • Humphries SE (1988) DNA polymorphisms of the apolipoprotein genes — their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis 72:89–108

    Article  CAS  PubMed  Google Scholar 

  • Jeenah M, Kessling A, Miller N, Humphries SE (1990) A G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 7:233–241

    CAS  PubMed  Google Scholar 

  • Jones KA, Yamamoto KR, Tjian R (1985) Two distinct transcription factors bind to HSV thymidine kinase promoter in vitro. Cell 42:559–572

    Article  CAS  PubMed  Google Scholar 

  • Kadonaga JT, Jones KA, Tjian R (1986) Promoter-specific activation of RNA polymerase II transcription by SP1. Trends Biochem Sci 11:20–23

    Article  CAS  Google Scholar 

  • Karathanasis SK, McPherson J, Zannis VI, Breslow JL (1983) Linkage of human apolipoprotein AI and CIII genes. Nature 304:371–373

    Article  CAS  PubMed  Google Scholar 

  • Karathanasis SK, Yunis J, Zannis VI (1986a) Structure, evolution and tissue-specific synthesis of human apolipoprotein AIV. Biochemistry 25:3962–3970

    Article  CAS  PubMed  Google Scholar 

  • Karathanasis SK, Oettgen P, Haddad IA, Antonarakis SE (1986b) Structure, evolution and polymorphisms of the human apolipoprotein A4 gene (apoA4). Proc Natl Acad Sci USA 83:8457–8461

    CAS  PubMed  Google Scholar 

  • Karathanasis SK, Ferris E, Hadda IA (1987) DNA Inversion within the apolipoprotein AI-CIII-AIV gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 82:6374–6378

    Google Scholar 

  • Kessling AM, Horsthemke B, Humphries SE (1985) A study of DNA polymorphism around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet 28:296–306

    CAS  PubMed  Google Scholar 

  • Kessling AM, Rajput-Williams J, Bainton D, Scott J, Miller N, Baker I, Humphries SE (1988a) DNA polymorphisms of the apolipoprotein AII and AI-CIII-AIV genes: a study in men selected for differences in high density lipoprotein cholesterol concentration. Am J Hum Genet 42:458–467

    CAS  PubMed  Google Scholar 

  • Kessling AM, Temple A, Taylor A, Hutson J, Hidalgo A, Hidalgo A, Humphries SE (1988b) A PvuII polymorphism in the 5′ flanking region of the apo AIV gene: detection of genetic variation determining apo AI and HDL-cholesterol concentration. Hum Genet 78:237–239

    Article  CAS  PubMed  Google Scholar 

  • Kinnunen PK, Virtanen JA, Vainio P (1983) Lipoprotein lipase and hepatic endothelial lipase: their role in plasma lipoprotein metabolism. Atheroscler Rev 7:65–105

    Google Scholar 

  • Knijff F, Rosseneu M, Beisiegel U, Keersgieter W, Frants RR, Havekes LM (1988) Apolipoprotein AIV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J Lipid Res 29:1621–1627

    PubMed  Google Scholar 

  • Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones W Jr, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245–1249

    CAS  PubMed  Google Scholar 

  • Kuusi T, Kesaniemi YA, Vuoristo M, Miettinen TA, Koskenvuo M (1987) Inheritance of high density lipoprotein lipase and hepatic lipase activity. Arteriosclerosis 4:421–425

    Google Scholar 

  • Lusis AJ (1988) Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 29:397–429

    CAS  PubMed  Google Scholar 

  • Menzel HJ, Boerwinkel E, Schrangel-Will S, Utermann G (1988) Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet 79:368–372

    Article  CAS  PubMed  Google Scholar 

  • Miller NE, Forde OH, Fhelle DS, Mjos OD (1977) The Trømsø heart study. High density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1:965–968

    CAS  PubMed  Google Scholar 

  • Moll PP, Michel VV, Weidman WH, Kottke BA (1989) Genetic determination of plasma apolipoprotein AI in a population-based sample. Am J Hum Genet 44:24–139

    Google Scholar 

  • Morrison JA, Laskarzewsk PM, Rauh JL, Brookman R, Mellies M, Frazer M, Khovry P, De Groot I, Kelly K, Glueck CJ (1979) Lipids, lipoproteins and sexual maturation during adolescence: the Princeton maturation study. Metabolism 28:641

    CAS  PubMed  Google Scholar 

  • Norum RA, Lakier JB, Goldstein S, Angel A, Goldberg RB, Block WD, Noffze DK, Dolphin PJ, Edelglass J, Bogorad DD, Alaupovic P (1982) Familial deficiency of apolipoproteins AI and CIII and precocious coronary-artery disease. N Engl J Med 306:1513–1519

    CAS  PubMed  Google Scholar 

  • Norusis MJ (1986) SPSS/PC+ for the IBM PC/XT/AT. SPSS, Chicago

  • Oettgen P, Antonarakis SE, Karathanasis SK (1986) PvuII polymorphic site upstream to the human apo CIII gene. Nucleic Acids Res 14:557

    Google Scholar 

  • Oram JF, Johnson CT, Brown TA (1987) Interaction of highdensity lipoprotein with its receptor on cultured fibroblasts and macrophages. Biol Chem 262:2405–2410

    CAS  Google Scholar 

  • Orchard TJ, Rodgers M, Hedley AJ, Mitchell JR (1981) Serum lipids in a teenage population: geographical, seasonal and familial factors. Int J Epidemiol 10:161

    CAS  PubMed  Google Scholar 

  • Ordovas JM, Civeira F, Genest J Jr, Craig S, Robbins AH, Meade T, Pocovi M, Frossard PM, Masharani U, Wilson PWF, Salem DN, Ward RH, Schaefer EJ (1991) Restriction fragment length polymorphisms of the apolipoprotein AI, CIII, AIV gene locus. Relationships with lipids, apolipoproteins and premature coronary artery disease. Atherosclerosis 87:75–86

    Article  CAS  PubMed  Google Scholar 

  • Pagani F, Sidoli A, Guidici GA, Barenghi L, Vergani C, Baralle FE (1990) Human apolipoprotein AI promotor polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 31:1371–1377

    CAS  PubMed  Google Scholar 

  • Paulweber B, Friedl W, Krempler F, Humphries SE, Sandhofer F (1988) Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease. Atherosclerosis 73:125–133

    Article  CAS  PubMed  Google Scholar 

  • Quarfordt SH, Michalopoulos G, Schirmer B (1982) The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat. J Biol Chem 257:14642–14647

    CAS  PubMed  Google Scholar 

  • Rees A, Stocks J, Sharpe CR, Vella MA, Shoulders CC, Katz J, Jowett NI, Baralle FE, Galton DJ (1985) DNA polymorphism in the apo-A-I-C-III gene cluster: association with hypertri-glyceridaemia. J Clin Invest 76:1090–1095

    CAS  PubMed  Google Scholar 

  • Rosseneu M, Van Biervliet JP, Bury J, Vinaimont N (1983) Isolation and characterization of lipoprotein profiles in newborns by density-gradient ultracentrifugation. Pediat Res 17:788–794

    CAS  PubMed  Google Scholar 

  • Rosseneu M, Michiels G, De Keersgieter W, Bury J, De Slijpere JP, Utermann G, Dieplinger H (1988) Human apolipoprotein A-IV quantitation by sandwich enzyme-linked immunosorbent assay. Clin Chem 34:739–743

    CAS  PubMed  Google Scholar 

  • Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich H (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491

    CAS  PubMed  Google Scholar 

  • Sastry KN, Seedorf U, Karathanasis SK (1988) Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types. Mol Cell Biol 8:605–614

    CAS  PubMed  Google Scholar 

  • Schmitz G, Niemann R, Brennhausen B, Krause R, Assman G (1985) Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl-CoA: cholesterol acyltransferase. EMBO J 4:2773–2779

    CAS  PubMed  Google Scholar 

  • Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, Gilligan M, Gambert P, Ball MJ (1991) Variation at the apo AI-CIII-AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 87:239–247

    Article  CAS  PubMed  Google Scholar 

  • Sokal RR, Rohlf G (1983) Biometry, 2nd edn. Freeman, San Francisco

    Google Scholar 

  • Steinmetz A, Utermann G (1985) Activation of lecithin: cholesterol acyltransferase by human apolipoprotein AIV. J Biol Chem 260:2258–2264

    CAS  PubMed  Google Scholar 

  • Thompson EA, Deeb S, Walker D, Motulsky AG (1988) The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 42:113–124

    CAS  PubMed  Google Scholar 

  • Vercaemst R, Rosseneu M, Van Biervliet JP (1983) Separation and of plasma lipoproteins by high-performance liquid chromatography. J Chromatogr 276:174–181

    CAS  PubMed  Google Scholar 

  • Vermeulen A (1973) The endocrine function of the human testis. In: James VHT, Seno M, Martino L (eds). Academic Press, New York, pp 91–103

  • Wile DB, Barbir M, Gallagher J, Myant NB, Ritchie CD, Thompson GR, Humphries SE (1989) Apolipoprotein AI gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo AI and HDL-cholesterol concentration. Atherosclerosis 78:9–18

    Article  CAS  PubMed  Google Scholar 

  • Yaari S, Even-Zohar S, Goldbourt U, Neufeld HN (1981) Associations of serum high-density lipoprotein and total cholesterol with total, cardiovascular and cancer mortality in a 7-year prospective study of 10000 men. Lancet 1:1011–1013

    CAS  PubMed  Google Scholar 

  • Xu C-F, Nanjee MN, Savill J, Talmud P, Angelico F, Del Ben M, Antonini R, Mazzarella B, Miller N, Humphries SE (1990) Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am J Hum Genet 47:429–439

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paul-Hayase, H., Rosseneu, M., Robinson, D. et al. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88, 439–446 (1992). https://doi.org/10.1007/BF00215679

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00215679

Keywords

Navigation